Key result
Hemodynamic monitoring with a pulmonary artery catheter can effectively guide clinical decision-making and optimize therapies for patients with cardiogenic shock on mechanical circulatory support.
Why the study?
Studies regarding the benefit of PACs are ambiguous, leading to variable use, and PAC use has not been evaluated in a randomized controlled trial in patients with cardiogenic shock with or without mechanical circulatory support.
Does hemodynamic monitoring with a pulmonary artery catheter improve decision-making and outcomes in patients with cardiogenic shock receiving mechanical circulatory support?
Does hemodynamic monitoring with a pulmonary artery catheter improve decision-making and outcomes in patients with cardiogenic shock receiving mechanical circulatory support?
This review provides a compelling rationale for the use of pulmonary artery catheter monitoring to guide therapy in patients with cardiogenic shock receiving mechanical circulatory support.
Answers are grounded in this paper and cite their sources.
PAC monitoring may guide CS therapy optimization amid MCS; leaves open definitive benefit given ambiguous evidence and variable use.
The recent widespread availability and use of mechanical circulatory support is transforming the management and outcomes of cardiogenic shock (CS). Clinical decision-making regarding the optimization of therapies for patients with CS can be guided effectively by hemodynamic monitoring with a pulmonary artery catheter (PAC). Because several studies regarding the benefit of PACs are ambiguous, the use of PACs is variable among clinicians treating patients with CS. More notable is that PAC use has not been studied as part of a randomized, controlled trial in patients with CS with or without mechanical circulatory support. Standardized approaches to hemodynamic monitoring in these patients can improve decision-making and outcomes. In this review, we summarize the hemodynamics of CS and mechanical circulatory support with PAC-derived measurements, and provide a compelling rationale for the use of PAC monitoring in patients with CS receiving mechanical circulatory support.
No takes yet. Share an insight, caveat, or question.
Saxena et al. (2020) conducted a review in Cardiogenic shock undergoing mechanical circulatory support. Hemodynamic monitoring with a pulmonary artery catheter (PAC) was evaluated. Hemodynamic monitoring with a pulmonary artery catheter can effectively guide clinical decision-making and optimize therapies for patients with cardiogenic shock on mechanical circulatory support.
Synapse has enriched 10 related papers. Consider them for comparative context: